ArticleBriefings in bioinformatics2025
Pepxml: ESM2-based extreme multilabel classification of pathogen-targeted antimicrobial peptides.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial Intelligence-Driven Antimicrobial Peptide Discovery: Prediction, Generation, Mining and Optimization.Probiotics and antimicrobial proteins · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In recent years, antimicrobial peptides (AMPs) have attracted interest as potential peptide antibiotic due to their broad-spectrum antibacterial activity and high target specificity. However, existing research on AMP prediction mainly focuses on their functional properties, such as antibacterial, antiviral, and anticancer. This emphasis has created a significant gap in identifying AMPs that specifically target pathogens. Given the large variety of pathogens and the sparsity and imbalance of labels, it is challenging to determine which specific pathogens AMPs can effective against. To address this issue, we present PepXML, a large language model-based tool for extreme multilabel classification of pathogen-targeted AMPs. Our first step involved constructing a benchmark dataset of AMPs and their corresponding targeted pathogens, sourced from public databases. In PepXML, the peptides are embedded using ESM2. Further, clustering on a specifically designed label co-occurrence graph and hard negative sampling were employed to address challenges on data sparsity and label imbalance. To validate the reliability of our predictive results, we conducted molecular docking studies focused on peptide-bilayer membrane interactions and performed molecular dynamics simulations to elucidate the mechanisms of peptide-pathogen interactions. We anticipate that PepXML will be a valuable resource for advancing peptide-based therapeutics. The data and Python codes of the PepXML model are available at https://github.com/YannanBin/PepXML.git.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.